Yu, L <br/><br/>
Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".  [electronic resource] 

 -  Atherosclerosis  Jul 1996 
 - 103-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9150 
<br/><br/><label>Standard No.: </label>10.1016/0021-9150(96)05828-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticholesteremic Agents--pharmacology<br/>Canada--epidemiology<br/>Cells, Cultured<br/>Enzyme Induction<br/>Enzyme Inhibitors--pharmacology<br/>Ethnicity--genetics<br/>Female<br/>Fibroblasts--metabolism<br/>France--ethnology<br/>Gene Expression Regulation--drug effects<br/>Haploidy<br/>Humans<br/>Hydroxymethylglutaryl CoA Reductases--genetics<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors<br/>Hyperlipoproteinemia Type II--drug therapy<br/>Lipoproteins, LDL--metabolism<br/>Lovastatin--pharmacology<br/>Male<br/>Prevalence<br/>RNA, Messenger--biosynthesis<br/>Receptors, LDL--genetics<br/>Sequence Deletion<br/>Transcription, Genetic<br/>Treatment Failure